Genomics England – The Generation Study – CAH included
The Generation Study is being carried out by Genomics England in partnership with the NHS. It is exploring the possible use of genome sequencing in newborn babies to identify a wide range of rare genetic conditions alongside the routine newborn blood spot screening. The study will include 100,000 newborns and the first participants are expected to join the study in the next few weeks.
As part of the study, Genomics England have created a list of rare conditions and associated genes that they will be looking for – and CAH is included. These conditions are chosen by following four key principles.
An extract of the list showing the types of CAH which are included is below:
| Condition Group | Gene | Condition name |
| Congenital adrenal hyperplasia | CYP17A1 | 17-alpha-hydroxylase/17,20-lyase deficiency |
| Congenital adrenal hyperplasia | CYP21A2 *This gene meets the principles to be included, however it is not currently being analysed due to further internal work being required | Congenital adrenal hyperplasia due to 21-hydroxylase deficiency |
| Congenital adrenal hyperplasia | CYP11B1 | Adrenal hyperplasia, congenital, due to 11-beta-hydroxylase deficiency |
| Congenital adrenal hyperplasia | HSD3B2 | Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency |
The list is being kept under constant review throughout the study and is subject to change as new evidence emerges. Genomics England is working with the NHS in England to ensure availability of treatments and to confirm that the genome sequencing technology used in the study can reliably identify changes in the genes causing these conditions.
The results of the study will add to evidence that will inform future decisions on using whole genome sequencing to support newborn screening. This includes using it to accelerate diagnosis and access to treatments for rare conditions.
More information
Genomics England homepage – https://www.genomicsengland.co.uk/
The Generation Study – https://www.genomicsengland.co.uk/initiatives/newborns
Recent Blog Posts
Liquid Hydrocortisone Discontinued in the UK
Liquid hydrocortisone injections have been discontinued in the UK, affecting emergency treatment for people with adrenal insufficiency. This follows the supply shortage reported in February 2025 -...
Medicine security – a national UK priority.
Concerns about medicines shortages in the UK have been highlighted in recent analysis from the House of Lords Public Services Committee and the Royal Pharmaceutical Society. The House of Lords Public Services Committee warns that medicines supply should be treated as...
2026 CAH Support Group Conference, 28th June, Sheffield
SUNDAY 28th JUNE 2026 9.30 -16:00 The Old Rectory, Handsworth, Sheffield, S13 9BZ theoldrectoryhandsworth.co.uk Those living with CAH and their families and friends are invited to the biennial conference of CAH Support Group. Visit our online booking page here to find...